Hydroxocobalamin Injection Shortage: Teva Pharmaceuticals Reports Supply Issues

What’s in Shortage

Hydroxocobalamin Injection (Brand Name: HYDROXOCOBALAMIN) is currently listed in a shortage status. This medication, which falls under the therapeutic category of “Other,” is provided in an injection dosage form. The specific presentation affected is the 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30).

Which Manufacturers Are Affected

The following manufacturer is currently reporting supply issues for this medication:

• Teva Pharmaceuticals USA, Inc.
  • Status: Unavailable
  • Notes: Estimated availability is currently To Be Determined (TBD).
  • Contact Information: 800-545-8800

Why There’s a Shortage

According to the FDA database, the reason for this shortage is a shortage of an active ingredient required for the production of the medication.

What Patients Should Do

If you are prescribed Hydroxocobalamin Injection, it is important to take proactive steps to manage your treatment:

• Consult your healthcare provider: Discuss this shortage with your doctor to determine the best course of action for your specific health needs. Do not discontinue or change your medication without professional medical advice.
• Speak with your pharmacist: Your pharmacist can provide information on current stock levels or potential timelines for when the medication might be back in stock.
• Contact the manufacturer: You may contact Teva Pharmaceuticals directly at 800-545-8800 for the most up-to-date information regarding their supply status.

Source

This information is based on the FDA Drug Shortage Database.

• Initial Posting Date: 11/04/2024
• Last Updated: 02/02/2026